Hero is the first automaker to announce a complete shutdown even though it is not mandated by any state government yet. Hero has factories in Haryana, Uttarakhand, Gujarat, Rajasthan and Andhra Pradesh

According to CoWIN portal, 13 small states and union territories have less than 10 private facilities where vaccination against COVID-19 infection is being conducted and out of these, five states and union territories have no private facilities for vaccination

Manufacturing scale up has been carried out in a stepwise manner across multiple facilities at Hyderabad and Bangalore, Bharat Biotech said in a statement

Production of Covaxin to rise 10 times in September; Coronavirus vaccine supplies for small states are being replenished in a week, says Harsh Vardhan

Congress accused the government for not providing adequate funds to state governments that were fighting a two front war  despite accumulating hundreds of crores of rupees in the PM CARES Fund

Honda said the replacement of the fuel pump in the affected cars will be carried out free of cost at its dealerships across India in a phased manner starting from 17th April 2021. Owners are being contacted individually

The Centre is providing financial support as grant to vaccine manufacturing facilities to enhance their production capacities.

ISA, as well as steelmakers have been deliberating with the government and points of concerns have been shared like a longer gestation time is required for steel mills to realise PLI benefits instead of five years, Dilip Oommen, President of Indian Steel Association (ISA) and CEO of AM/NS (ArcelorMittal/Nippon Steel) India says

The company has got permission from the Drug Controller General of India (DCGI) to import the vaccine. Reddy's is also going to tap domestically contract manufactured vaccines as and when companies are allowed to start commercial manufacturing in India

The Production Linked Incentive Scheme aims to build an Indian manufacturing base across 13 key sectors. What works. What doesn't

Indian vaccine manufacturers, including SII, Bharat Biotech, Panacea Biotech, Sanofi's Shanta Biotech, Biological E, Hester Biosciences and Zydus Cadila, have an installed capacity to manufacture 8.2 billion doses of different vaccines per year

India's two approved COVID-19 vaccine makers - Serum Institute of India and Bharat Biotech - are struggling to keep pace with the increasing demand for COVID-19 vaccines within India

In conversation with Pramod Kaushik, President & MD, Hexagon India

Share of the gold refiner touched an intraday high of Rs 524.4, rising 9.23% against previous close of Rs 480.10 on BSE

Health Secretary Rajesh Bhushan asked state health departments to initiate due consultations with public and private sector employers and management to prepare for workplace coronavirus vaccination drives

Due to the new wave of outbreaks in India right now, the Indian government has stepped up their vaccination programmes, which means that they've made less doses available for the rest of the world, Seth Berkley, CEO of Gavi told CBS News

Share of the pharma firm rose 19.99% to Rs 220.85 against previous close of Rs 184.40 on BSE. The stock opened with a gain of 15.68% at Rs 212.90

Production of Sputnik V at Panacea Biotec sites will help facilitate global supply of Sputnik V to international partners of RDIF.

The Gurgaon-based firm, which sold around 53,000 electric two-wheelers last fiscal to lead the vertical, also aims to set up around 20,000 charging stations across the country over the next two years to ease range anxiety issues

A vaccine ingredient made by Emergent BioSolutions -- one of about 10 companies that Johnson and Johnson is using to speed up manufacturing of its recently approved vaccine -- did not meet quality standards, J&J said on Wednesday